Article citationsMore>>

Kahwaji, J., Jordan, S.C., Najjar, R., Wongsaroj, P., Choi, J., Peng, A., et al. (2016) Six-year Outcomes in Broadly Hla-Sensitized Living Donor Transplant Recipients Desensitized with Intravenous Immunoglobulin and Rituximab. Transplant International, 29, 1276-1285.
https://doi.org/10.1111/tri.12832

has been cited by the following article:

• TITLE: Renal Transplant in a Hypersensitive Patient: A Case Report

  AUTHORS: Cristian León-Rabanal, Luis Zegarra-Montes, Rodrigo Castro de la Mata Guerra-García, Justo Dueñas-Chuquimia, Estefano Marcelo Benites, Andrea Valdez

  KEYWORDS: HLA Hypersensitivity, Desensitization, Renal Transplants

  JOURNAL NAME: Open Journal of Nephrology, Vol.15 No.4, November 11, 2025

  ABSTRACT: In hypersensitized patients, Kidney Transplant (KT) rates are low due to the risk of organ loss due to rejection. Desensitization (DS) protocols have been developed to prevent rejection, increasing their success. We present the case of a 65-year-old female patient with Chronic Kidney Disease (CKD) associated with Hypertensive Nephroangiosclerosis (HNA) on Hemodialysis (HD). She was documented to have hypersensitization against Human Leukocyte Antigen (HLA), presenting Donor-Specific Antibodies (DSA) detected by solid-phase techniques, making her a high-immunological risk patient. With a suitable living donor available, a desensitization protocol was initiated. DS treatment consisted of plasmapheresis, Intravenous Immunoglobulin (IVIG) and Rituximab, with a successful KT result.